BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. Common Stock (BHST) Revenue
Annual & quarterly revenue history · segment & region breakdown
BHST · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBioHarvest Sciences Inc. Common Stock trailing twelve-month (TTM) revenue is $0.04B, an increase of 37.00% year-over-year from $0.03B in FY2025.
Revenue trend
2025 – 2014 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.03B | +$0.01B | +37.00% |
| 2024-12-31 | $0.03B | +$0.01B | +98.77% |
| 2023-12-31 | $0.01B | +$0.01B | +130.48% |
| 2022-12-31 | $0.01B | +$0.00B | +161.56% |
| 2021-12-31 | $0.00B | +$0.00B | +430.81% |
| 2020-12-31 | $0.00B | +$0.00B | +81.65% |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2019-04-30 | $0.00B | +$0.00B | — |
| 2018-04-30 | $0.00B | +$0.00B | — |
| 2017-04-30 | $0.00B | +$0.00B | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BioHarvest Sciences Inc. Common Stock receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BioHarvest Sciences Inc. Common Stock reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BioHarvest Sciences Inc. Common Stock's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BHST revenue · 4 questionsBHST's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 37.00% year-over-year from $0.03B in FY2025.
▸ Source: FMP · BioHarvest Sciences Inc. Common Stock SEC filings · GAAP · BioHarvest Sciences Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026